GALDY (Galderma Group AG) Current Deferred Taxes Liabilities : $0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Galderma Group AG's current deferred tax liabilities for the quarter that ended in Dec. 2024 was $0 Mil.

Galderma Group AG Current Deferred Taxes Liabilities Historical Data

The historical data trend for Galderma Group AG's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Current Deferred Taxes Liabilities Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Current Deferred Taxes Liabilities

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Current Deferred Taxes Liabilities	-	-	-	-

Galderma Group AG Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

GDERF:USA GALDz:UK PY3:Germany GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.